First described in the early 1980s, antiphospholipid syndrome (APS) is a unique form of
acquired autoimmune thrombophilia in which patients present with clinical features of …

Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

For patients with antiphospholipid syndrome (APS), the consensus is to treat those who
develop thrombosis with long-term oral anticoagulation therapy and to prevent obstetric …

Antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy
complications in the presence of persistent antiphospholipid antibodies (APLA). Laboratory …

The specific value of IgA Anti-β2glycoprotein I antibodies (aB2GP1) in the diagnosis and
management of antiphospholipid syndrome (APS) is still controversial and a matter of active …

The international classification criteria for definite antiphospholipid syndrome (APS) include
three laboratory measurements: lupus anticoagulant (LA), IgG and IgM isotypes of anti …

Abstract Purpose of Review Elucidating the pathogenic mechanisms mediated by
antiphospholipid antibodies (aPL) might exert important clinical implications in pediatric …

Background Anticardiolipin (aCL) and anti-β2 glycoprotein I (aβ2GPI) immunoglobulin A
(IgA) antiphospholipid antibodies (aPL) have shown to associate with thrombosis and …

Anti‐phospholipid syndrome (APS) recapitulates the link between autoimmunity and
pregnancy failure: Acquired anti‐phospholipid antibodies (aPL) play a pathogenic role in …

Update on the pathogenesis and treatment of the antiphosphol... : Current Opinion in
Rheumatology Update on the pathogenesis and treatment of the antiphospholipid syndrome …